Phase 1 Start~month

Phase 1 Start: A Multicenter, Randomized, Double-Blind, 2-Treatment Arm Study to Assess Comparative Pharmacokinetic

Drug
stage
Indication
Melanoma

Other upcoming events for ALVO

Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 1 Start: A Multicenter, Randomized, Double-Blind, 2-Treatment Arm Study to Assess Comparative Pharmacokinetic — ALVO Phase 1 Start | BioSniper